Thompson, Morgan
Schnoll, Robert
Serrano, Katrina
Leone, Frank
Gross, Robert
Collman, Ronald G.
Ashare, Rebecca L. http://orcid.org/0000-0003-4664-009X
Funding for this research was provided by:
National Institute on Drug Abuse (R01 DA033681, K24 DA045244, R01 DA042682, R01 DA044906)
National Institute of Allergy and Infectious Diseases (P30 AI045008)
National Institute of Mental Health (P30 MH097488)
Article History
Received: 24 September 2019
Accepted: 2 January 2020
First Online: 14 January 2020
Compliance with ethical standards
:
: Dr. Schnoll receives medication and placebo free of charge from Pfizer for clinical trials and has provided consultation to Pfizer, GlaxoSmithKline, and Curaleaf. Dr. Gross serves on a Pfizer Data and Safety Monitoring Board for a drug unrelated to smoking or HIV. Dr. Ashare has an investigator-initiated grant from Novo Nordisk for a drug unrelated to the current study.